Research funderUnited States
A research funder in the United States. Rare cancers.
What they do
Based in the United States. Focus: rare cancers. Listed by NCI MyPART Advocacy Partners. US tax-exempt organisation. Latest IRS filing: $446,172.
Compiled from coalition directories and charity registers; the organisation’s site did not publish a summary we could quote.
On the record
More in Rare and less common cancersBrowse all →
United States
The Children's Tumor Foundation drives treatments and a cure for NF — neurofibromatosis type 1 (NF1) and all types of schwannomatosis (SWN), including NF2-related…
United States
A patient group in the United States. Fanconi anemia and Fanconi-associated cancers.
United States
A patient group in the United States. PTEN hamartoma tumor syndrome and cancer predisposition.
United States
Our mission is improving quality of life and health outcomes for VHL (Von Hippel-Lindau) patients, families, and caregivers.
United States · Research funder
TargetCancer Foundation advances research, provides patient support, and drives progress in the understanding and treatment of rare cancers.
United States · Coalition
The Rare Cancer Coalition, formalized in 2017 as a program under the NORD Membership umbrella, unites advocacy organizations working in rare cancers to collaborate on…
Triangle
